Tom,
Your projection sounds reasonable for Oct. 1998 The only new instrument that was for sale in this quarter is the Rosys Plato . As I understand it, it was to start selling this month. Do you have any info on that? Did they sell any ? when will that revenue hit the bottom line...this quarter or next ?
Also, what about Wilm's $1.3 Million he owes us? IMO, that pay back should be applied directly to earnings. That 1.3 was profit that should have been reported as EPS. Instead it went into Wilm's pocket.
I have mentioned this before. It is important. The earnings for BLUD, because of this mis-appropriation, have been reported as too low.
$ 1.3M is 16 cents per share ...over 1 year that is 4 cents a quater, that makes the EPS of .06 look like .10 . The street would have been a LOT happier with that number each quarter.
Obviously, the company wants to keep a low profile on this. I know they have taken steps to get re-payment...liens , etc. Why don't they sell Wilm's stock, or exercise his options ?
If that 1.3 M is paid this quarter it will appear in the bottom line and MAYBE noted as an extraordinary item.
|
